The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
Open accessAbstract
The transduction of primary T cells to express chimeric T cell receptors (cTCR) for redirected targeting of tumor cells is an attractive strategy for generating tumor-specific T cells for adoptive therapy. However, tumor cells rarely provide costimulatory signals and hence cTCRs that transmit just a CD3zeta signal can only initiate target cell killing and interferon-gamma release and fail to induce full activation. Although incorporation of a CD28 component results in IL-2 release and limited proliferation, T cell activation remains incomplete. OX40 transmits a potent and prolonged T cell activation signal and is crucial for maintaining an immunological response. We hypothesize that the CD28-OX40-CD3zeta tripartite cytoplasmic domain will provide a full complement of activation, proliferation, and survival signals for enhanced anti-tumor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Gross, G., Waks, T., & Eshhar, Z. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10024 · Cited by 1,590
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
An inducible caspase 9 safety switch for T-cell therapy
Straathof, K. C., Pulè, M. A., Yotnda, P., Dotti, G., Vanin, E. F., Brenner, M. K., Heslop, H. E., Spencer, D. M., & Rooney, C. M. (2005) · Blood · doi:10.1182/blood-2004-11-4564 · Cited by 742
Self-citationBrentjens, R. J., Latouche, J.-B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D., Larson, S., Weiss, M., Rivière, I., et al. (2003) · Nature Medicine · doi:10.1038/nm827 · Cited by 669
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
Finney, H. M., Lawson, A. D. G., Bebbington, C. R., & Weir, A. N. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2791 · Cited by 546
Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses
Gramaglia, I., Weinberg, A. D., Lemon, M., & Croft, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6510 · Cited by 527
PATERSON, D., JEFFERIES, W., GREEN, J., BRANDON, M., CORTHESY, P., PUKLAVEC, M., & WILLIAMS, A. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90122-2 · Cited by 447
CD28/B7 Costimulation: A Review
Greenfield, E. A., Nguyen, K. A., & Kuchroo, V. K. (1998) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v18.i5.10 · Cited by 441
Mitsuyasu, R. T., Anton, P. A., Deeks, S. G., Scadden, D. T., Connick, E., Downs, M. T., Bakker, A., Roberts, M. R., June, C. H., Jalali, S., et al. (2000) · Blood · doi:10.1182/blood.v96.3.785 · Cited by 425
Expression and function of OX40 ligand on human dendritic cells
Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., & Delespesse, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3838 · Cited by 420
Haematopoietic cell transplantation as immunotherapy
Appelbaum, F. R. (2001) · Nature · doi:10.1038/35077251 · Cited by 411
Gramaglia, I., Jember, A., Pippig, S. D., Weinberg, A. D., Killeen, N., & Croft, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3043 · Cited by 409
Molecules and mechanisms of the graft-versus-leukaemia effect
Bleakley, M., & Riddell, S. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1365 · Cited by 392
Stüber, E., Neurath, M., Calderhead, D., Perry Fell, H., & Strober, W. (1995) · Immunity · doi:10.1016/1074-7613(95)90031-4 · Cited by 390
Mallett, S., Fossum, S., & Barclay, A. N. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08211.x · Cited by 379
Deeks, S. G., Wagner, B., Anton, P. A., Mitsuyasu, R. T., Scadden, D. T., Huang, C., Macken, C., Richman, D. D., Christopherson, C., June, C. H., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0611 · Cited by 324
Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions
Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M. L., Greenfield, E. A., Baum, P. R., Fanslow, W. C., Calderhead, D. M., Freeman, G. J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80143-0 · Cited by 321
Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes.
Brocker, T., & Karjalainen, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1653 · Cited by 296
Weinberg, A. D., Wegmann, K. W., Funatake, C., & Whitham, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1818 · Cited by 252
Signaling through OX40 (CD134) breaks peripheral T-cell tolerance
Bansal-Pakala, P., Gebre-Hiwot Jember, A., & Croft, M. (2001) · Nature Medicine · doi:10.1038/90942 · Cited by 230
WALKER, R. E., Bechtel, C. M., Natarajan, V., Baseler, M., Hege, K. M., Metcalf, J. A., Stevens, R. A., Hazen, A., Blaese, R. M., Chen, C. C., et al. (2000) · PubMed · doi:10.1182/blood.v96.2.467 · Cited by 222
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.
Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J. M., Claassen, E., Noelle, R. J., & Fell, H. P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5261 · Cited by 202
Rossig, C., Bollard, C. M., Nuchtern, J. G., Rooney, C. M., & Brenner, M. K. (2002) · Blood · doi:10.1182/blood.v99.6.2009 · Cited by 201
Self-citationHaynes, N. M., Trapani, J. A., Teng, M. W. L., Jackson, J. T., Cerruti, L., Jane, S. M., Kershaw, M. H., Smyth, M. J., & Darcy, P. K. (2002) · Blood · doi:10.1182/blood-2002-04-1041 · Cited by 197
It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation
Kane, L. P., Lin, J., & Weiss, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02264-0 · Cited by 182
Brocker, T. (2000) · Blood · doi:10.1182/blood.v96.5.1999 · Cited by 181
CD28-Independent Costimulation of T Cells by OX40 Ligand and CD70 on Activated B Cells
Akiba, H., Oshima, H., Takeda, K., Atsuta, M., Nakano, H., Nakajima, A., Nohara, C., Yagita, H., & Okumura, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7058 · Cited by 175
Rossig, C., Bollard, C. M., Nuchtern, J. G., Merchant, D. A., & Brenner, M. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1457 · Cited by 161
Self-citationHaynes, N. M., Snook, M. B., Trapani, J. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.182 · Cited by 139
Niederman, T. M. J., Ghogawala, Z., Carter, B. S., Tompkins, H. S., Russell, M. M., & Mulligan, R. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092562399 · Cited by 125
Dual-specific T cells combine proliferation and antitumor activity
Kershaw, M. H., Westwood, J. A., & Hwu, P. (2002) · Nature Biotechnology · doi:10.1038/nbt756 · Cited by 114
Blazar, B. R., Sharpe, A. H., Chen, A. I., Panoskaltsis‐Mortari, A., Lees, C. J., Akiba, H., Yagita∥, H., Killeen, N. P., & Taylor, P. A. (2003) · Blood · doi:10.1182/blood-2002-10-3048 · Cited by 114
A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection
Humphreys, I. R., Walzl, G., Edwards, L., Rae, A. J., Hill, S., & Hussell, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030351 · Cited by 106
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes
Pinthus, J. H., Waks, T., Malina, V., Kaufman‐Francis, K., Harmelin, A., Aizenberg, I., Kanety, H., Ramon, J., & Eshhar, Z. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22284 · Cited by 86
Carboni, S., Aboul‐Enein, F., Waltzinger, C., Killeen, N. P., Lassmann, H., & Rossi, C. P. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.07.001 · Cited by 64
Pulè, M. A., Finney, H. M., & Lawson, A. D. G. (2003) · Cytotherapy · doi:10.1080/14653240310001488 · Cited by 63
Self-citation
Cited by
CAR-T cell therapy: current limitations and potential strategies
Sterner, R. C., & Sterner, R. M. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00459-7 · Cited by 2,926
Long, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3838 · Cited by 1,815
The Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Milone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.83 · Cited by 1,197
Louis, C. U., Savoldo, B., Dotti, G., Pule, M., Yvon, E., Myers, G. D., Rossig, C., Russell, H. V., Diouf, O., Liu, E., et al. (2011) · Blood · doi:10.1182/blood-2011-05-354449 · Cited by 1,163
Self-citation
Metadata
- Authors
- Pulè, M. A., Straathof, K. C., Dotti, G., Heslop, H. E., Rooney, C. M., & Brenner, M. K.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 12
- Issue
- 5
- Pages
- 933-941
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1999843922
- Cited by
- 487
- References
- 40
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.